This research paper will provide an overview on Burkitt lymphoma disease and its pathophysiology.
Burkitt lymphoma has become one of the most prevalent cancers in the past two decades in which the number of people with the disease has increased, especially in Africa. Research indicates that burkitt lymphoma has emerged to be the fastest growing tumor among humans.
Burkitt lymphoma was identified in 1956 by Denis Burkitt, and it is one of the principal forms on non-Hodgkin’s lymphoma, which affect immune cells. Epidemiological reports indicate that, Burkitt lymphoma is more prevalent in malaria endemic regions than other regions although it greatest impact is experienced in Africa where it affects children who are also experiencing episodes of malaria and Epstein-Barr viral infection. Epstein-Barr virus is believed to be the principal cause of infectious mononucleosis, which leads to the transformation of B-cells into tumor cells, especially following malaria episode which weakens the immune system. This is probably the reason as to why 98% of Burkitt lymphoma cases in Africa are linked to Epstein-Barr infection. Elsewhere in the U.S, the incidence of Burkitt lymphoma accounts for about 1,200 people annually in which 59% of all the patients diagnosed with the disease being adults above the age of 40 years.
In Burkitt lymphoma, lymphocytes, primarily the B-cells of the immune system which are involved in cell-mediated immune response during pathogenic infections are affected. In most cases, the prevalence of the disease is enhanced by infections which weaken the immune system. For instance, malaria, Epstein-Barr viral infection and HIV are some of the diseases associated with a decrease of the immune system response. In addition, therapies which are immune-suppressive, especially those involved in organ transplantation to prevent transplant rejection and highly-active antiretroviral therapy (HAART) used for HIV/AIDS treatment facilitate the formation of cancerous B-cells. However, the physiology and anatomy of Burkitt lymphoma encompasses diverse aspects compared to other forms cancer.
Table of Contents
1. Summary
2. Introduction
3. Forms of Burkitt Lymphoma and their Effects on Body Physiology
4. Anatomical Regions Affected by Burkitt Lymphoma
5. Risk Factors of Burkitt Lymphoma
6. Pathophysiology
7. Physiological Effects of Burkitt Lymphoma Symptoms
8. Treatment of Burkitt Lymphoma: How Therapies Affect Physiology
9. Conclusion
Research Objectives and Themes
This paper provides a comprehensive overview of Burkitt lymphoma, focusing on its epidemiology, pathophysiology, and the various factors contributing to its development. The central research objective is to examine how different forms of the disease affect human physiology and to discuss the underlying genetic and environmental triggers, such as the Epstein-Barr virus and malaria, that drive B-cell transformation.
- Epidemiological classification and global distribution of Burkitt lymphoma forms.
- Anatomical localization and the role of lymphoid tissue in disease manifestation.
- Pathophysiological mechanisms, specifically DNA mutations, oncogenes, and suppressor genes.
- The impact of co-infections like malaria and Epstein-Barr virus on immune system function.
- Therapeutic approaches including chemotherapy, monoclonal antibodies, and stem cell therapy.
Excerpt from the Book
Pathophysiology
The pathophysiology of Burkitt lymphoma encompasses some complexity because there are quite a number of things which have not yet been understood about how these cancers occur. However, there has been some progress in research which has led to the unraveling of some mysteries associated to Burkitt lymphoma and other forms of non-Hodgkin’s lymphoma in general. For instance, scientists have identified the mechanism involved in the transformation of normal B-lymphocytes into lymphoma cells and this phenomenon is associated to some changes in an individual’s genomic material. It is believed that oncogenes and suppressor genes play a significant role in DNA changes observed in Burkitt lymphoma. In theory, oncogenes are responsible for speeding up cell division for cellular proliferation or organ development. On the other hand, suppressor genes, also known as tumor suppressor genes are responsible for controlling cell death by slowing down cell division. These two processes occur uniformly to ensure efficient growth and development, but fatal consequences occur when imbalances are experienced. In most cases, DNA changes occur during cell division in which the DNA replicates into two replicas before an existing cell divides into two new copies (American Cancer Society, 2013). However, such replication processes are not perfect, so errors occur at times through DNA mutations, which produce abnormal DNA molecules. This implies that some genes on chromosomes are affected. One of the most common DNA mutations involves deletion or duplication of genes.
Summary of Chapters
Summary: Provides an overview of Burkitt lymphoma as a rapidly growing tumor, identifying its three principal forms and general risk factors.
Introduction: Outlines the historical context of the disease and its strong correlation with Epstein-Barr virus and malaria infection in specific regions.
Forms of Burkitt Lymphoma and their Effects on Body Physiology: Categorizes the disease into sporadic, endemic, and immunodeficiency-related forms, detailing their distinct demographic and geographical patterns.
Anatomical Regions Affected by Burkitt Lymphoma: Discusses how the disease targets lymphoid tissues in organs such as lymph nodes, the spleen, and the bone marrow.
Risk Factors of Burkitt Lymphoma: Examines factors like age, gender, chemical exposure, and chronic infections that contribute to the development of the condition.
Pathophysiology: Explains the molecular mechanisms, including DNA translocations and the activation of the C-myc oncogene, that lead to malignant cell transformation.
Physiological Effects of Burkitt Lymphoma Symptoms: Describes the physical manifestations of the disease, such as abdominal masses and facial bone deformation.
Treatment of Burkitt Lymphoma: How Therapies Affect Physiology: Reviews current medical interventions, focusing on chemotherapy, monoclonal antibodies, and stem cell transplantation.
Conclusion: Synthesizes the main findings regarding the epidemiology and genetic basis of Burkitt lymphoma.
Keywords
Burkitt lymphoma, Non-Hodgkin’s lymphoma, Epstein-Barr virus, B-lymphocytes, Oncology, Pathophysiology, Malaria, DNA mutation, C-myc oncogene, Tumor suppressor genes, Immune system, Lymphoid tissue, Chemotherapy, Immunodeficiency, Epidemiology.
Frequently Asked Questions
What is the primary focus of this document?
The document provides a detailed overview of Burkitt lymphoma, covering its classification, pathophysiological mechanisms, associated risk factors, and current therapeutic strategies.
What are the three main forms of Burkitt lymphoma described?
The text classifies the disease into sporadic Burkitt lymphoma, endemic Burkitt lymphoma, and immunodeficiency-related Burkitt lymphoma.
What is the primary research goal?
The goal is to analyze the disease's origin, the role of external pathogens like the Epstein-Barr virus, and how genetic changes lead to the transformation of normal B-cells into tumors.
Which scientific methodology is used here?
The work utilizes a review of epidemiological reports, clinical research, and molecular pathology studies to synthesize current knowledge regarding the disease.
What does the main body of the text cover?
It covers the classification of the disease, its anatomical impact, the molecular role of oncogenes and suppressor genes, and the physiological effects of various treatment methods.
Which keywords best characterize this work?
The most relevant keywords include Burkitt lymphoma, Epstein-Barr virus, C-myc oncogene, B-lymphocytes, and lymphoid tissue.
How does malaria contribute to the development of endemic Burkitt lymphoma?
Malaria weakens the immune system and inhibits the immune response against the Epstein-Barr virus, creating an environment that facilitates B-cell transformation.
Why is the C-myc oncogene critical to this cancer?
Activation of the C-myc oncogene, often through chromosomal translocation, leads to the overproduction of proteins that drive rapid and uncontrolled cell proliferation.
What is the role of monoclonal antibody therapy in treatment?
These antibodies are designed to identify cancerous B-cells and signal the immune system to destroy them, offering a targeted alternative to traditional chemotherapy.
Why is early diagnosis complicated in adults?
In many adult cases, the disease can present as painless lymphadenopathy, which often masks its underlying severity and delays identification.
- Arbeit zitieren
- Patrick Kimuyu (Autor:in), 2017, Burkitt Lymphoma. Forms, Effects, Risk Factors, Treatment, München, GRIN Verlag, https://www.hausarbeiten.de/document/381285
